Two new Ebola vaccines to join DR Congo clinical trial
Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus.
Publicerad
Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus.
Denna sammanställning är automatiskt framtagen ur 1 källrapporter från 1 oberoende ägargrupper. Endast information som finns i källunderlaget har använts.